← Olin overview

Olin vs Carlit Co.: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Olin Corporation (OLN)

Q3 2026
▲2▼2

Olin's Huntsman merger advances amid weak demand and a Q2 loss

  • Huntsman merger clears key hurdles Olin's all-stock merger with Huntsman won shareholder approval and passed U.S. antitrust review. The deal targets $300–400 million in cost savings and could add $8–11 per share, though integration risks remain.

    This is the biggest new corporate event that could reshape Olin and lift its value.

  • Weak chemicals demand causes surprise Q2 loss Soft demand for chemicals led to an unexpected second-quarter loss, sending the stock down 16% in one day. The company also gave weak third-quarter profit guidance of $160–200 million.

    This was the main negative shock that drove the stock lower during the period.

  • Epoxy and Winchester sales lift profit Strong sales in Epoxy and Winchester businesses helped adjusted EBITDA rise 8.6% to $191.3 million. A tightening chlor-alkali market could also benefit Olin over the long term.

    These bright spots show parts of the business are performing well despite overall weakness.

  • Analyst downgrade and plant disruption Citi cut its price target to $17, pointing to broad weakness in the chemicals sector. A disruption at Olin's Freeport plant added to operational concerns.

    These events reinforced negative sentiment and highlighted ongoing challenges.

August 2026
▲2▼2

Olin's Huntsman merger advances, but weak chemicals demand and losses weigh

  • Weak Q2 results and soft Q3 guidance Olin posted a wider second-quarter loss of $13.3 million as sales slipped 0.9% to $1.74 billion, and guided third-quarter EBITDA to $160–200 million, including a roughly $20 million hit from a Freeport plant disruption. Weak profits and guidance pressure the stock.

    This is the core earnings reality that sets the baseline for OLN's price this period.

  • Huntsman merger clears key hurdles Shareholders of both companies approved the all-stock merger on August 25, and the U.S. antitrust waiting period expired in September. The deal would create a larger chemicals platform with $300 million in planned cost savings, a major potential boost for Olin.

    The merger is the biggest company-specific catalyst driving OLN's outlook and valuation.

  • Epoxy and Winchester strength offset chlor alkali weakness Epoxy sales jumped 27.4% and Winchester ammunition sales rose 11.8%, lifting adjusted EBITDA 8.6% to $191.3 million and beating revenue expectations. These growing businesses are helping cushion the decline in the larger chlor alkali and vinyls segment.

    It shows which parts of Olin are actually growing and supporting profits despite overall weakness.

  • Citi cuts price target on weak chemical demand Citi kept a Neutral/High Risk rating on Olin and lowered its price target to $17 from $19, citing weak demand that is limiting gains from higher oil and feedstock costs. It also cut targets across many North American chemical peers, signaling broad sector pressure.

    This is the latest analyst view showing demand headwinds that could keep OLN's stock under pressure.

Latest
▲2▼2

Olin's Huntsman merger advances, but weak chemicals demand and losses weigh

  • Weak Q2 results and soft Q3 guidance Olin posted a wider second-quarter loss of $13.3 million as sales slipped 0.9% to $1.74 billion, and guided third-quarter EBITDA to $160–200 million, including a roughly $20 million hit from a Freeport plant disruption. Weak profits and guidance pressure the stock.

    This is the core earnings reality that sets the baseline for OLN's price this period.

  • Huntsman merger clears key hurdles Shareholders of both companies approved the all-stock merger on August 25, and the U.S. antitrust waiting period expired in September. The deal would create a larger chemicals platform with $300 million in planned cost savings, a major potential boost for Olin.

    The merger is the biggest company-specific catalyst driving OLN's outlook and valuation.

  • Epoxy and Winchester strength offset chlor alkali weakness Epoxy sales jumped 27.4% and Winchester ammunition sales rose 11.8%, lifting adjusted EBITDA 8.6% to $191.3 million and beating revenue expectations. These growing businesses are helping cushion the decline in the larger chlor alkali and vinyls segment.

    It shows which parts of Olin are actually growing and supporting profits despite overall weakness.

  • Citi cuts price target on weak chemical demand Citi kept a Neutral/High Risk rating on Olin and lowered its price target to $17 from $19, citing weak demand that is limiting gains from higher oil and feedstock costs. It also cut targets across many North American chemical peers, signaling broad sector pressure.

    This is the latest analyst view showing demand headwinds that could keep OLN's stock under pressure.

July 2026
▲2▼1

Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock

  • Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.

    This is the latest major step in the merger and directly affects OLN's future value.

  • Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.

    This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.

  • Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.

    This is a new analyst view on a key market driver that could improve Olin's future earnings.

  • Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.

    This explains the financial rationale and potential value of the merger, a key driver for OLN.

▲2▼1

Olin's merger advances, but weak chemicals demand and a surprise loss weigh on the stock

  • Olin-Huntsman merger approved by shareholders Shareholders overwhelmingly approved the all-stock merger with Huntsman, creating a $12.5 billion chemicals company. The deal promises over $400 million in cost savings, which could boost future profits and support the stock. It is expected to close in the first half of 2027, pending regulatory approval.

    This is the latest major step in the merger and directly affects OLN's future value.

  • Surprise Q2 loss and 16% stock drop Olin reported a surprise loss of $0.12 per share, missing expectations for a profit, and revenue fell short. The stock dropped about 16% in one day. Weak chlor alkali sales and merger-related costs drove the loss, showing the company's core business is struggling.

    This is a new negative event that directly caused a sharp price decline and reflects fundamental weakness.

  • Chlor-alkali market tightening could lift Olin Hotchkis & Wiley sees North American chlor-alkali supply and demand tightening over the next five-plus years, which could raise prices and volumes. As the region's swing producer, Olin could benefit more than peers. This long-term trend offers a potential recovery path.

    This is a new analyst view on a key market driver that could improve Olin's future earnings.

  • Merger synergies valued, but integration costs and risks remain UBS estimates the merger's cost savings could add $8–$11 per share in value, mainly from procurement, operations, and overhead cuts. However, the deal also brings $10.6 million in acquisition costs and execution risk, and it does not expand into new markets, so the benefit depends on successful integration.

    This explains the financial rationale and potential value of the merger, a key driver for OLN.

Carlit Co., Ltd. (4275.JP)